Neparvis Европска Унија - Исландски - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - hjartabilun - lyf sem hafa áhrif á renín-angíótensín kerfið - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Amiloride/HCT Alvogen (Diuramin) Tafla 5/50 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

amiloride/hct alvogen (diuramin) tafla 5/50 mg

alvogen ehf. - amiloridum hýdróklóríð; hydrochlorothiazidum inn - tafla - 5/50 mg

Kairasec Tafla 8 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

kairasec tafla 8 mg

medical valley invest ab - candesartanum cílexetíl - tafla - 8 mg